23 May 2013
Keywords: Alvogen, Par pharma, Production facility, R&D, Generics
Article | 23 October 2009
New Jersey, USA-based Alvogen Group says that it has acquired R&D capabilities from Par Pharmaceutical. .As part of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2009
22 May 2013
© 2013 thepharmaletter.com